Healthcare -
Biotechnology - NASDAQ - US
$ 1.045
-6.7 %
$ 119 M
Market Cap
-0.64
P/E
FATE - TOTAL RECEIVABLES
Total Receivables FATE - Fate Therapeutics, Inc.
1.83 M
LAST VALUE
-54.12%
2 YEAR CAGR
29.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR